Pharmacogenomic screen identifies KMT2D mutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma | Conference Paper individual record
author list (cited authors)
Mazumdar, T., Kalu, N. N., Peng, S., Tong, P., Shen, L. i., Wang, J., ... Johnson, F. M.
publication date
published in